Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials Post author:Sam Post published:March 4, 2018 Post category:BioPharma Dermira plans to shutter the program and move on to more promising compounds. Source: BioSpace You Might Also Like Sweden's Lipigon Inks $100 Million Pact with Drug Giant AstraZeneca PLC to Identify New Cholesterol Drugs April 11, 2016 Mallinckrodt Pays $117M for This Bay Area Biotech and Its Failed Liver Drug November 1, 2017 MRI Interventions Announces $13.25 Million Private Placement May 25, 2017
Sweden's Lipigon Inks $100 Million Pact with Drug Giant AstraZeneca PLC to Identify New Cholesterol Drugs April 11, 2016
